Latest Kaiser Health News Stories
KHN’s Shefali Luthra discusses the recent Trump administration lawsuit regarding the HIV-prevention drug Truvada.
A USC-Brookings analysis finds that the New York plan to resolve disputes between providers and insurers without leaving patients on the hook might actually be driving up costs in the system.
Patients were thrilled last month when UVA announced it would scale back lawsuits and provide more financial assistance, but the excitement has waned.
A few hundred hospitals have banded together to sue drugmakers in state courts, but far more are staying on the sidelines to avoid ‘unflattering attention’ about their role in the opioid crisis.
A lawsuit against Group Health surfaces as the White House promotes Medicare Advantage for seniors.
House Democrats start legislative work on House Speaker Nancy Pelosi’s prescription drug pricing bill; health is again a featured player in the Democratic presidential candidate debate; and courts around the country hold up President Donald Trump’s health agenda. This week, Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Sutter Health has reached a tentative settlement in an antitrust suit brought by the California Attorney General’s Office. Details have not been made public.
President Donald Trump has ordered that legal immigrants obtain health insurance within 30 days of arriving or prove they can pay for any possible medical need ― another policy certain to be challenged in court. Meanwhile, health issues continue to play a major role in campaign 2020. This week, Paige Winfield Cunningham of The Washington Post, Alice Miranda Ollstein of Politico and Julie Appleby of Kaiser Health News join KHN’s Julie Rovner to discuss these issues and more.
Patients at VCU Health will no longer be taken to court and can more easily get financial assistance to pay their bills.
Scammers bent on defrauding Medicare are embracing the new technologies of remote diagnosis. Federal law enforcement is cracking down.
President Donald Trump, dogged by an impeachment inquiry, tries to change the subject by unveiling an executive order aimed at expanding the role of private Medicare health plans. The Trump administration also launched an effort this week to expand “wellness” programs aimed at getting people with insurance to practice better health habits – even though research has shown the efforts don’t generally improve health or save money. This week, Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
A sheriff’s deputy in central Georgia filed a lawsuit Wednesday against Houston County, whose employee insurance plan has denied coverage for her transgender-related health care. The decision would likely result in a ruling that affects the entire state, if not the entire Southeast, and comes after decisions in Wisconsin and Iowa sided with other transgender patients.
The Freedom of Information Act lawsuit could spur the Centers for Medicare & Medicaid Services to release audits that document up to $650 million in overcharges.
Washington is abuzz with impeachment talk, but what impact would such a move have on congressional action on prescription drug prices and surprise bills? Also, a study out this week shows that health insurance costs for both employers and workers continue to rise. This week, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
The legal fight over the Trump administration’s new rule barring health clinics that receive federal family planning grants from referring women for abortion services played out before a divided federal appeals court Monday. Here are key takeaways.
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
State attorneys general took legal action to stop the sale of rape kits that would be useless as evidence in court.